Teclistamab + talquetamab targeting BCMA and GPRC5D shows promising efficacy in patients with RRMM ecancer 5:20 1 year ago 50 Далее Скачать
RedirecTT-1 Study: Dual Targeting of BCMA and GPRC5D in RRMM Pts with Teclistamab and Talquetamab International Myeloma Foundation 9:41 1 year ago 422 Далее Скачать
Bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab VJHemOnc – Video Journal of Hematology & HemOnc 4:15 1 year ago 776 Далее Скачать
Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM International Myeloma Foundation 7:25 3 years ago 396 Далее Скачать
Teclistamab, a BCMA × Cd3 Bispecific Antibody, in Pts with RRMM: Updated Phase 1 Results International Myeloma Foundation 9:57 3 years ago 1 122 Далее Скачать
What should myeloma patients know about talquetamab? International Myeloma Foundation 3:44 1 year ago 2 424 Далее Скачать
Real-world efficacy & safety of teclistamab in patients with BCMA-pretreated R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:39 6 months ago 184 Далее Скачать
Going beyond BCMA-targeting agents in myeloma: GPRC5D and FcRH5-targeting therapies VJHemOnc – Video Journal of Hematology & HemOnc 2:14 1 year ago 125 Далее Скачать
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM International Myeloma Foundation 7:06 3 years ago 1 071 Далее Скачать
Evaluation of Teclistamab in RRMM Patients Following Exposure to Other BCMA-Targeted Agents International Myeloma Foundation 5:53 2 years ago 293 Далее Скачать
Talquetamab: GPRC5D-CD3 bispecific antibody in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 4:15 3 years ago 550 Далее Скачать
First-in-human study of talquetamab: a GPRC5D-CD3 bispecific antibody for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 2:25 3 years ago 167 Далее Скачать
FcRH5 & GPRC5D bispecific antibodies: antigen targets beyond BCMA for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:41 1 year ago 138 Далее Скачать
Promise of GPRC5D-targeted CAR-T therapies in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:36 1 year ago 96 Далее Скачать
Understanding Myeloma Therapy Targets BCMA and GPRC5D Patient Empowerment Network 3:46 4 months ago 30 Далее Скачать
MonumenTAL-1: talquetamab in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 10:11 1 year ago 537 Далее Скачать
Updated data: Phase 1/2 MajesTEC-1 study evaluating teclistamab, a BCMA x CD3 bispecific antibody ecancer 7:25 2 years ago 130 Далее Скачать
TECVAYLI (Teclistamab) Everything You Need to Know HealthTree University for Multiple Myeloma 22:21 1 year ago 6 018 Далее Скачать
Talquetamab | Therapies on the horizon HealthTree University for Multiple Myeloma 17:55 1 year ago 1 401 Далее Скачать
Beyond BCMA: GPRC5D & FcRH5 VJHemOnc – Video Journal of Hematology & HemOnc 5:21 3 years ago 318 Далее Скачать
